Skip to main content

Posts

Showing posts with the label Ashwagandha

Seed Germination in Wild and Cultivated Varieties of Withania somnifera (L.) Dunal | Chapter 04 | Modern Research in Botany Vol. 1

Aim: Withania somnifera (L.) Dunal or Ashwagandha is a valuable medicinal plant having a consistent demand in pharmaceutical industries. Traditionally it is propagated from seeds but it’s germination capacity is poor. So in the present study different methods were considered to sort out a suitable method that can be used for its cultivation in the field of Hazaribag, Jharkhand, India. Study Design: The study was done in the laboratory and field of Hazaribag, Jharkhand, India. Place and Duration of Study: Department of Botany, Vinoba Bhave University, Hazaribag, Jharkhand, India. The study was carried out from July 2012 to August 2012 and again from mid June 2013 to August 2013. Methodology: Different pre germination treatments including 24 hours water soaking, 48 hours water soaking, mechanical scarification, heat treatment at 50 degree Celsius (5 min, 10 min, 15 min) and Gibberellic acid [GA3] (250 µg/l, 500 µg/l, 1000 µg/l) treatments were proposed. The mean germinatio...

Ashwagandha and Its Active Ingredient, Withanolide A, Increase Activation of the Phosphatidylinositol 3’ Kinase/Akt Cascade in Hippocampal Neurons | Chapter 04 | Recent Advances in Biological Research Vol. 5

Aims: To determine if whether, in a hippocampal neuron culture model subjected to nutrient deprivation stress (simulating degenerative disease state), Ashwagandha and/or two of its putative active ingredients, withanolide A or withaferin A, affect any of the following: neurite outgrowth, neuronal survival, activation of the pro-survival PI-3K/Akt and MAPK cascades, phosphorylation of CREB and expression of brain-derived neurotrophic factor (BDNF). Study Design: To primary rat embryonic hippocampal neurons in culture, half of which were subjected to nutrient deprivation stress, inhibitors of the PI-3K/Akt and MAPK cascade (LY294002 and PD98059, respectively) were applied, followed by Ashwagandha, withanolide A or withaferin A. Methodology: Neuronal survival was determined by using fluorescently labeled markers for live vs dead cells and by lactate dehydrogenase assay. Average neurite length was measured under phase-contrast microscopy. And intracellular signal transd...